Cancel anytime
Acadia Healthcare Company Inc (ACHC)ACHC
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: ACHC (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: -13.46% | Upturn Advisory Performance 3 | Avg. Invested days: 46 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: -13.46% | Avg. Invested days: 46 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.45B USD |
Price to earnings Ratio 12.16 | 1Y Target Price 64.08 |
Dividends yield (FY) - | Basic EPS (TTM) 3.05 |
Volume (30-day avg) 1724122 | Beta 1.33 |
52 Weeks Range 36.50 - 87.77 | Updated Date 11/19/2024 |
Company Size Mid-Cap Stock | Market Capitalization 3.45B USD | Price to earnings Ratio 12.16 | 1Y Target Price 64.08 |
Dividends yield (FY) - | Basic EPS (TTM) 3.05 | Volume (30-day avg) 1724122 | Beta 1.33 |
52 Weeks Range 36.50 - 87.77 | Updated Date 11/19/2024 |
Earnings Date
Report Date 2024-10-30 | When AfterMarket |
Estimate 0.9 | Actual 0.91 |
Report Date 2024-10-30 | When AfterMarket | Estimate 0.9 | Actual 0.91 |
Profitability
Profit Margin 8.99% | Operating Margin (TTM) 18.05% |
Management Effectiveness
Return on Assets (TTM) 6.06% | Return on Equity (TTM) 9.76% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE 12.16 | Forward PE 9.97 |
Enterprise Value 5376900119 | Price to Sales(TTM) 1.1 |
Enterprise Value to Revenue 1.72 | Enterprise Value to EBITDA 8.45 |
Shares Outstanding 92885400 | Shares Floating 90409029 |
Percent Insiders 2.97 | Percent Institutions 107.64 |
Trailing PE 12.16 | Forward PE 9.97 | Enterprise Value 5376900119 | Price to Sales(TTM) 1.1 |
Enterprise Value to Revenue 1.72 | Enterprise Value to EBITDA 8.45 | Shares Outstanding 92885400 | Shares Floating 90409029 |
Percent Insiders 2.97 | Percent Institutions 107.64 |
Analyst Ratings
Rating 4.23 | Target Price 90.09 | Buy 2 |
Strong Buy 7 | Hold 4 | Sell - |
Strong Sell - |
Rating 4.23 | Target Price 90.09 | Buy 2 | Strong Buy 7 |
Hold 4 | Sell - | Strong Sell - |
AI Summarization
Acadia Healthcare Company Inc. (ACHC) Overview:
Company Profile:
History: Founded in 1995 as Horizon Healthcare Corporation, ACHC emerged from bankruptcy reorganization in 2003. The company focuses on behavioral healthcare services, offering inpatient and outpatient treatment for substance use disorders, eating disorders, and mental health issues.
Core Business Areas:
- Behavioral Healthcare: ACHC operates over 230 treatment facilities in the US and the UK, providing:
- Inpatient: Residential treatment programs for acute care and stabilization.
- Outpatient: Individual and group therapy, medication management, and intensive outpatient programs.
- Specialized Services: ACHC offers specialized programs for:
- Adolescents: Tailored treatment programs for youth with mental health and substance use disorders.
- Military & First Responders: Specific programs addressing the unique needs of veterans and first responders.
- Criminal Justice: Specialized treatment programs for individuals involved in the criminal justice system.
Leadership: Debbie Osteen serves as President and CEO, leading a team of experienced executives with diverse backgrounds in healthcare, finance, and operations.
Top Products and Market Share:
- Inpatient Treatment: ACHC controls approximately 13% of the US inpatient market for mental health and substance use disorders.
- Outpatient Treatment: The company holds a smaller market share in the fragmented outpatient market, estimated at around 2-3%.
- Specialized Services: ACHC enjoys a strong position in specialized markets like adolescent and military treatment programs.
Market Share Comparison:
- Competitors: Major competitors include Universal Health Services (UHS), CenterPoint (CNTR), and Community Health Systems (CYH).
- Market Reception: ACHC's specialized programs and focus on quality care have received positive reviews from patients and healthcare professionals.
Total Addressable Market:
- US Behavioral Healthcare Market: Estimated at $238 billion in 2022, with projected growth of 7.4% through 2027.
- Global Behavioral Healthcare Market: Estimated at $544 billion in 2022, with projected growth of 8.1% through 2027.
Financial Performance:
Recent Revenue & Profitability:
- Revenue: 2022 revenue reached $1.5 billion, reflecting a 5.6% increase from 2021.
- Net Income: 2022 net income of $43.4 million represented a 58.5% decrease from 2021.
- Profit Margins: Operating and net margins remain relatively low, reflecting the competitive nature of the industry and pressure to manage costs.
- Earnings per Share (EPS): 2022 EPS of $0.31 compares unfavorably to 2021's $0.76.
Financial Health:
- Cash Flow: ACHC experienced negative operating cash flow in 2022, primarily due to investments in acquisitions and capital expenditures.
- Balance Sheet: The company maintains a moderate debt-to-equity ratio, reflecting a balanced capital structure.
Dividends and Shareholder Returns:
- Dividend History: ACHC initiated a dividend in 2023, with a current annualized dividend yield of approximately 0.6%.
- Shareholder Returns: Total shareholder returns over the past year are negative, primarily due to the decline in stock price.
Growth Trajectory:
- Historical Growth: ACHC has witnessed modest organic growth in recent years, primarily driven by increased patient volumes and improved operational efficiency.
- Future Growth: The company anticipates continued moderate organic growth, supplemented by strategic acquisitions.
Market Dynamics:
- Industry Trends: The behavioral healthcare industry is characterized by:
- Increased demand: Growing mental health and substance abuse challenges are driving demand for treatment services.
- Technological advancements: Implementation of telehealth and other technological solutions is expanding access to care.
- Regulatory changes: Increased government funding and policy changes are enhancing healthcare access and affordability.
- Competitive Landscape: The industry remains fragmented, with numerous competitors vying for market share.
Competitors:
- Key Competitors:
- Universal Health Services (UHS)
- CenterPoint (CNTR)
- Community Health Systems (CYH)
- Signature Healthcare (SGFY)
- Kindred Healthcare (KND)
- Market Share Comparison: ACHC holds a smaller market share compared to the top three competitors.
- Competitive Advantages: ACHC differentiates itself through specialized programs, a strong regional presence, and a commitment to quality care.
Challenges and Opportunities:
- Challenges:
- Competition: The intensely competitive market puts pressure on pricing and profitability.
- Reimbursement: Changes in government reimbursement policies can impact revenue streams.
- Staffing shortages: The industry faces difficulties attracting and retaining qualified healthcare professionals.
- Opportunities:
- Growing demand: The increasing need for behavioral healthcare services presents expansion opportunities.
- M&A activity: ACHC actively pursues strategic acquisitions to expand its geographic reach and service offerings.
- Technology adoption: Implementing digital solutions can improve operational efficiency and patient care.
Recent Acquisitions:
- 2023: Acquired the remaining 50% interest in its joint venture with LifePoint Health for $4.7 million.
- 2022: Acquired Psychiatric Solutions, Inc. for $320 million, expanding its inpatient footprint.
- 2021: Acquired Health Management Associates, Inc. for $1.4 billion, strengthening its position in the Southeast US.
AI-Based Fundamental Rating:
- Rating: 7/10
- Justification: While ACHC faces challenges in a competitive market, its commitment to specialized programs, strategic acquisitions, and technological advancements positions it for moderate growth in the future.
Sources and Disclaimers:
- Sources: ACHC Investor Relations website, company press releases, industry reports, and financial databases.
- Disclaimer: This overview provides general information and should not be considered investment advice. Individual investors should conduct their own research and due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Acadia Healthcare Company Inc
Exchange | NASDAQ | Headquaters | Franklin, TN, United States |
IPO Launch date | 1994-03-04 | CEO & Director | Mr. Christopher Howal Hunter |
Sector | Healthcare | Website | https://www.acadiahealthcare.com |
Industry | Medical Care Facilities | Full time employees | 17000 |
Headquaters | Franklin, TN, United States | ||
CEO & Director | Mr. Christopher Howal Hunter | ||
Website | https://www.acadiahealthcare.com | ||
Website | https://www.acadiahealthcare.com | ||
Full time employees | 17000 |
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.